Skip to Content
 
Center for International Blood and Marrow Transplant Research

P-6366

Main Content

Return to Listing

Transplantation and Cellular Therapy | 2026

Cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome following axicabtagene ciloleucel or brexucabtagene autoleucel chimeric antigen receptor T-cell therapy: Center for International Blood and Marrow Transplant Research data.

Frigault MJ, Maziarz RT, Amoloja T, Burke L, Bhatt V, Moskop A, Pasquini M, DiPersio JF

PubMed
PMID: 42537846

Abstract
Related Articles

CIBMTR Study #: CM21-120